Recombinant Saccharomyces cerevisiae Methylsterol monooxygenase (ERG25)

What is the biochemical function of ERG25 in Saccharomyces cerevisiae?

ERG25 encodes C-4 methyl sterol oxidase, which catalyzes the first of three sequential steps required to remove two C-4 methyl groups from sterol intermediates during ergosterol biosynthesis in yeast . Specifically, ERG25 performs three sequential oxidation reactions:

• Conversion of 4α-methyl-zymosterol to 4α-hydroxymethyl-5α-cholesta-8,24-dien-3β-ol

• Conversion of 4α-hydroxymethyl-5α-cholesta-8,24-dien-3β-ol to 4α-formyl-5α-cholesta-8,24-dien-3β-ol

• Conversion of 4α-formyl-5α-cholesta-8,24-dien-3β-ol to 4α-carboxy-5α-cholesta-8,24-dien-3β-ol

Each of these reactions requires molecular oxygen and reduced cytochrome b as cofactors. The enzyme functions within the ergosterol biosynthesis pathway, which is essential for maintaining proper membrane fluidity and permeability in fungi .

What is the structural characterization of ERG25?

ERG25 in S. cerevisiae encodes a 309-amino acid polypeptide with a calculated molecular mass of 36.48 kDa . The protein sequence contains several notable structural features:

• A C-terminal endoplasmic reticulum retrieval signal (KKXX motif) that maintains localization in the ER membrane

• Three histidine-rich clusters that show similarity to those found in eukaryotic membrane desaturases and bacterial monooxygenases (alkane hydroxylase and xylene monooxygenase)

• Metal binding motifs similar to those in membrane desaturases-hydroxylases, which are likely involved in catalytic function

Western blot analysis using antibodies against an Erg25-GST fusion protein has detected two forms of the protein: a 34 kDa form and a 75 kDa form. Both proteins are membrane-bound and contain a single N-glycosyl unit, with immunofluorescence data suggesting localization in both the endoplasmic reticulum and plasma membrane .

How does ERG25 relate to homologous proteins in other organisms?

ERG25 shares functional homology with methyl sterol oxidases in various organisms, forming part of a conserved pathway for sterol biosynthesis:

• In humans, a homologue of ERG25 has been identified, cloned, sequenced, and mapped to chromosome 4q32-34. This suggests evolutionary conservation of the sterol biosynthesis pathway from fungi to humans .

• In Candida albicans, ERG251 functions as the primary C-4 sterol methyl oxidase of the alternative sterol pathway, with ERG25 existing as a paralog that is normally expressed at lower levels than ERG251 .

• The histidine-rich clusters found in ERG25 show similarity to those in bacterial monooxygenases, suggesting a conserved catalytic mechanism across different enzyme families involved in oxidation reactions .

The conservation of this enzyme across different organisms underscores its fundamental importance in sterol metabolism and membrane biogenesis.

What are the optimal conditions for expressing recombinant ERG25 in heterologous systems?

When expressing recombinant S. cerevisiae ERG25 in heterologous systems, several methodological considerations are crucial:

• Expression System Selection:

  • E. coli systems often result in inclusion body formation due to the membrane-associated nature of ERG25

  • Yeast-based expression systems (S. cerevisiae or P. pastoris) typically provide better results due to appropriate post-translational modifications

  • Insect cell/baculovirus systems can be effective for generating properly folded, active enzyme

• Construct Design:

  • Include the complete 930 bp open reading frame encoding the 309 amino acid protein

  • Consider adding a C-terminal purification tag that won't interfere with the KKXX ER retrieval signal

  • For membrane extraction studies, preserve the histidine-rich clusters essential for catalytic activity

• Cultivation Parameters:

  • Growth at 30°C is optimal for expression in yeast systems

  • Consider iron supplementation in media as ERG25 activity has shown relationship to iron availability, though transcription is not directly iron-regulated

  • Monitor ergosterol pathway flux during expression to prevent toxicity from sterol intermediate accumulation

Purification typically requires careful membrane solubilization with mild detergents followed by affinity chromatography, with enzyme activity often requiring reconstitution in appropriate lipid environments to restore native catalytic function.

How can researchers accurately measure the enzymatic activity of recombinant ERG25?

Measuring the enzymatic activity of recombinant ERG25 requires specialized analytical techniques:

• Substrate Preparation:

  • The natural substrate, 4α-methyl-zymosterol, must be prepared from yeast strains with blocks in the ergosterol pathway

  • Alternatively, radiolabeled (³H or ¹⁴C) synthetic substrates can be used for higher sensitivity

• Reaction Conditions:

  • Buffer composition: typically 50-100 mM phosphate or Tris-HCl (pH 7.2-7.5)

  • Required cofactors: molecular oxygen, NADPH, and a cytochrome b electron donor system

  • Optimal temperature: 30°C for yeast ERG25

• Activity Measurement Methods:

  • Chromatographic Analysis:

    • GC-MS or LC-MS/MS to quantify substrate consumption and product formation

    • HPLC with UV detection for monitoring sterol intermediates

  • Spectrophotometric Assays:

    • Monitoring NADPH oxidation at 340 nm as an indirect measure of activity

    • Oxygen consumption measurement using oxygen electrodes

• Data Analysis:

  • Calculate enzyme kinetic parameters (Km, Vmax) for all three sequential reactions

  • Evaluate potential product inhibition effects

The most reliable assessment combines multiple analytical approaches, as ERG25 catalyzes three sequential oxidation reactions that must be monitored independently to fully characterize enzymatic function .

What strategies can be employed to study the membrane topology and subcellular localization of ERG25?

Understanding ERG25's membrane topology and subcellular localization requires a multifaceted approach:

• Computational Prediction:

  • Hydropathy profile analysis to identify transmembrane domains

  • Topology prediction algorithms to determine orientation of protein segments

• Biochemical Approaches:

  • Protease Protection Assays:

    • Treat intact microsomes with proteases to determine exposed protein regions

    • Compare proteolytic patterns before and after membrane permeabilization

  • Chemical Modification:

    • Use membrane-impermeable reagents to label exposed residues

    • Mass spectrometry to identify modified sites

• Fluorescence Microscopy:

  • GFP-tagging strategies (N-terminal vs. C-terminal) to visualize localization

  • Co-localization with established ER and plasma membrane markers

  • Live-cell imaging to monitor trafficking between compartments

• Immunological Methods:

  • Generate antibodies against specific domains of ERG25

  • Immunofluorescence under permeabilizing and non-permeabilizing conditions

  • Immunogold electron microscopy for high-resolution localization

Previous research has demonstrated that ERG25 primarily localizes to the endoplasmic reticulum, consistent with its KKXX ER retrieval signal, but a portion also localizes to the plasma membrane . This dual localization may reflect different functional roles or trafficking dynamics that warrant further investigation.

How does ERG25 integrate with other enzymes in the ergosterol biosynthesis pathway?

ERG25 functions as part of a coordinated enzyme network in the ergosterol biosynthesis pathway:

• Pathway Position:

  • ERG25 catalyzes reactions after the formation of 4,4-dimethylzymosterol

  • It works in sequential coordination with ERG26 (C-4 decarboxylase) and ERG27 (3-keto reductase) to remove both C-4 methyl groups

• Metabolic Flux Control:

  • ERG25 activity serves as a potential rate-limiting step in sterol demethylation

  • The enzyme appears to be regulated by end products of the ergosterol pathway rather than by iron availability, despite its dependence on iron for catalytic function

• Interaction Network:

  Enzyme	Interaction Type	Functional Significance
  ERG26	Sequential action	Decarboxylates ERG25's product
  ERG27	Physical/functional	Forms complex for efficient C-4 demethylation
  ERG11	Regulatory	Azole targeting of ERG11 affects ERG25 substrate availability
  ERG24	Preceding enzyme	Provides substrate precursors

• Regulatory Mechanisms:

  • Post-translational modifications (likely glycosylation) as evidenced by the detection of both 34 kDa and 75 kDa forms of the protein

  • Transcriptional regulation potentially linked to sterol intermediate accumulation

Understanding these interactions is crucial for interpreting phenotypes of ERG25 mutations and for designing experiments that accurately reflect pathway dynamics rather than isolated enzyme activities.

What are the implications of ERG25 mutations for antifungal drug development?

ERG25 represents a promising but complex target for antifungal development:

• Target Validation:

  • ERG25 is essential for viability in S. cerevisiae, as demonstrated by the non-viability of disruption mutants

  • It plays a crucial role in ergosterol biosynthesis, an established target pathway for antifungal agents

• Resistance Mechanism Insights:

  • In Candida albicans, research on the ERG25 paralog ERG251 revealed that its dysfunction leads to azole tolerance through accumulation of non-toxic alternative sterols

  • Single allele dysfunction of ERG251 has been identified as a recurrent mechanism of acquired azole tolerance

• Structure-Activity Relationships:

  • The histidine-rich clusters in ERG25 provide potential binding sites for metal-chelating inhibitors

  • Inhibitors targeting ERG25 would likely need to be fungal-specific to avoid affecting the human homologue

• Synergistic Drug Approaches:

  • Targeting ERG25 in combination with other ergosterol pathway enzymes might enhance efficacy

  • Combining ERG25 inhibitors with iron chelators could potentially provide synergistic effects based on the enzyme's relationship with iron metabolism

Researchers exploring ERG25 as an antifungal target should consider the potential for resistance development and cross-resistance with existing azole antifungals, as demonstrated by studies on related enzymes in pathogenic fungi .

How can gene editing techniques be applied to study ERG25 function in vivo?

Modern gene editing approaches offer powerful tools for investigating ERG25 function:

• CRISPR-Cas9 Applications:

  • Domain-Specific Mutations:

    • Target the histidine-rich clusters to assess their role in catalytic function

    • Modify the ER retrieval signal to investigate localization requirements

  • Promoter Engineering:

    • Create conditional expression systems to regulate ERG25 levels

    • Introduce reporter elements to monitor expression dynamics

• Heterologous Complementation:

  • Express human or pathogenic fungal homologues in S. cerevisiae erg25 mutants

  • Assess functional conservation and species-specific differences

  • Evaluate the impact of specific mutations identified in drug-resistant clinical isolates

• Experimental Design Considerations:

  • Given that ERG25 is essential, use plasmid shuffling techniques with URA3-marked wild-type copies

  • Implement degron-based systems for conditional protein depletion

  • Consider dual targeting of ERG25 and its paralog when working in organisms like C. albicans

• Phenotypic Analysis Framework:

  Mutation Type	Expected Phenotype	Analytical Method
  Catalytic site	Sterol intermediate accumulation	GC-MS sterol profiling
  Localization signal	Mislocalization, altered function	Microscopy + lipid analysis
  Regulatory region	Expression level changes	qRT-PCR, Western blot
  Humanized chimeras	Altered drug sensitivity	MIC determinations

When designing gene editing experiments, researchers should account for the potential lethality of complete ERG25 dysfunction and consider the use of heterozygous mutations or partial function alleles to investigate aspects of enzyme function that might be masked in null mutants .

What are common challenges in purifying active recombinant ERG25 and how can they be addressed?

Purifying active recombinant ERG25 presents several technical challenges:

• Membrane Protein Solubilization:

  • Challenge: ERG25's membrane association makes it difficult to extract in active form

  • Solution: Screen detergents systematically (DDM, CHAPS, digitonin) at different concentrations and temperature conditions to identify optimal solubilization conditions that maintain native conformation

• Maintaining Enzymatic Activity:

  • Challenge: Loss of activity during purification due to cofactor dissociation

  • Solution: Supplement buffers with stabilizing agents such as glycerol (10-20%), ensure presence of reducing agents, and consider including lipids that mimic the native membrane environment

• Aggregation Issues:

  • Challenge: Tendency to form aggregates during concentration steps

  • Solution: Use sucrose gradient centrifugation, size exclusion chromatography under optimized buffer conditions, and carefully control protein concentration throughout purification

• Co-factor Requirements:

  • Challenge: ERG25 requires iron and electron transfer systems for activity

  • Solution: Include appropriate metal ions in purification buffers and reconstitute with cytochrome b for activity assays

• Recommended Purification Protocol Outline:

  Step	Method	Critical Parameters
  Expression	Yeast or insect cell system	Temperature, induction timing
  Membrane isolation	Differential centrifugation	Buffer composition, protease inhibitors
  Solubilization	Mild detergent treatment	Detergent:protein ratio, time, temperature
  Affinity purification	His-tag or alternative tag	Imidazole concentration, flow rate
  Activity preservation	Reconstitution in liposomes	Lipid composition, protein:lipid ratio

For meaningful functional studies, researchers should verify enzyme activity after purification using multiple complementary assays rather than relying solely on protein purity assessments .

How can researchers accurately analyze the complex sterol profiles resulting from ERG25 manipulation?

Analysis of sterol profiles requires sophisticated analytical approaches:

• Sample Preparation:

  • Extraction Protocol:

    • Alkaline hydrolysis of yeast cells to release sterols

    • Liquid-liquid extraction with non-polar solvents (hexane, petroleum ether)

    • Saponification to remove esterified sterols when analyzing free sterols

  • Derivatization:

    • TMS (trimethylsilyl) derivatization for GC-MS analysis

    • Appropriate internal standards for quantification

• Analytical Techniques:

  • GC-MS Analysis:

    • Use of DB-5MS or similar columns for sterol separation

    • Selected Ion Monitoring (SIM) for targeted analysis of known intermediates

    • Full scan mode for discovery of unexpected sterol species

  • LC-MS/MS Approaches:

    • Reverse phase chromatography with C18 columns

    • Multiple Reaction Monitoring (MRM) for specific sterol transitions

    • High-resolution MS for accurate mass determination

• Data Interpretation Challenges:

  • Challenge: Complex sterol profiles with multiple isomeric compounds

  • Solution: Use authentic standards when available, rely on established fragmentation patterns, and compare retention indices

• Key Sterol Intermediates to Monitor:

  Sterol	m/z (as TMS derivative)	Biological Significance
  4,4-dimethylzymosterol	498	Substrate accumulation indicates ERG25 deficiency
  4α-hydroxymethyl-5α-cholesta-8,24-dien-3β-ol	514	First reaction product
  4α-formyl-5α-cholesta-8,24-dien-3β-ol	512	Second reaction product
  4α-carboxy-5α-cholesta-8,24-dien-3β-ol	528	Third reaction product
  Ergosterol	468	Final pathway product indicates complete flux

When analyzing results, researchers should consider that changes in sterol profiles might induce compensatory adaptations in membrane composition, including altered phospholipid profiles and fatty acid composition, which may require complementary lipidomic analyses for comprehensive interpretation .

What approaches can be used to investigate ERG25 interactions with other proteins in the ergosterol biosynthesis pathway?

Investigating protein-protein interactions involving ERG25 requires specialized techniques:

• In Vivo Approaches:

  • Split-Protein Complementation Assays:

    • BiFC (Bimolecular Fluorescence Complementation) to visualize interactions

    • Split-ubiquitin assays specifically designed for membrane protein interactions

  • FRET/BRET Analysis:

    • Fluorescence or bioluminescence resonance energy transfer between ERG25 and potential partners

    • Live cell imaging to monitor interaction dynamics

  • Co-immunoprecipitation with Membrane Adaptations:

    • Crosslinking prior to solubilization to preserve transient interactions

    • Tandem affinity purification with optimized detergent conditions

• In Vitro Methods:

  • Reconstituted Systems:

    • Co-reconstitution of purified ERG25 with other ergosterol pathway enzymes in liposomes

    • Activity assays to assess functional coupling

  • Surface Plasmon Resonance:

    • Immobilization strategies adapted for membrane proteins

    • Direct measurement of binding kinetics and affinities

• Genetic Interaction Mapping:

  • Synthetic genetic array analysis to identify functional interactions

  • Dosage suppression screens to identify proteins that can compensate for ERG25 defects

• Integrative Structural Biology:

  • Cryo-EM analysis of purified complexes

  • Crosslinking mass spectrometry to identify interaction interfaces

  • Computational modeling informed by experimental constraints

Previous research suggests potential functional coupling between ERG25, ERG26, and ERG27 in the C-4 demethylation complex. Additionally, the relationship between ERG25 and its paralog (as seen with ERG251 and ERG25 in C. albicans) warrants investigation, as the inability to delete both genes simultaneously suggests functional compensation between these enzymes . These interaction studies provide crucial insight into the organization of the ergosterol biosynthesis pathway as a potential multienzyme complex rather than a series of independent catalytic steps.

How might systems biology approaches enhance our understanding of ERG25's role in cellular metabolism?

Systems biology offers powerful frameworks for contextualizing ERG25 function:

• Metabolic Flux Analysis:

  • Use isotope labeling to trace carbon flow through the ergosterol pathway

  • Quantify how ERG25 activity affects global metabolic redistributions

  • Model the impact of ERG25 inhibition on cellular energy requirements

• Multi-omics Integration:

  • Combine transcriptomics, proteomics, and lipidomics data from ERG25 mutants

  • Identify compensatory mechanisms and regulatory networks

  • Map the ripple effects of ERG25 dysfunction on cell wall organization, stress responses, and other cellular processes

• Computational Modeling:

  • Develop kinetic models of the complete ergosterol pathway

  • Simulate the impact of ERG25 mutations on sterol homeostasis

  • Predict emergent properties from ERG25 interactions with other pathway components

• Network Analysis Framework:

  Data Type	Analysis Approach	Expected Insights
  Transcriptome	Co-expression networks	Regulatory connections
  Metabolome	Correlation analysis	Pathway crosstalk
  Genetic interactions	Epistasis mapping	Functional relationships
  Phenome	Multi-parameter phenotyping	Physiological impacts

The integration of these approaches promises to reveal how ERG25 functions within the broader context of cellular metabolism, potentially uncovering unexpected connections to other pathways and providing a more comprehensive understanding of sterol metabolism regulation .

What comparative genomic insights might be gained from studying ERG25 homologues across fungal species?

Comparative genomic analysis of ERG25 across fungal species offers valuable evolutionary and functional insights:

• Sequence Conservation Patterns:

  • Identify absolutely conserved residues likely essential for catalytic function

  • Map variable regions that might confer species-specific regulation or substrate preferences

  • Trace the evolutionary history of gene duplications (as seen with ERG25/ERG251 in C. albicans)

• Structure-Function Relationship:

  • Correlate natural sequence variations with differences in sterol profiles

  • Identify potential adaptive changes in pathogenic fungi

  • Predict functional consequences of polymorphisms identified in clinical isolates

• Regulatory Element Analysis:

  • Compare promoter architectures across species to identify conserved regulatory motifs

  • Map the evolution of transcriptional networks controlling sterol biosynthesis

  • Identify species-specific regulatory mechanisms

• Taxonomic Distribution Analysis:

  Fungal Group	ERG25 Features	Functional Implications
  Saccharomycotina	Single copy in most species	Core metabolic function
  Candida species	Gene duplication (ERG25/ERG251)	Functional specialization
  Filamentous fungi	Variable copy number	Potential metabolic adaptations
  Basidiomycetes	Divergent sequences	Alternative catalytic mechanisms

This comparative approach can reveal how evolutionary pressures have shaped ERG25 function across fungal lineages, providing insights into adaptation mechanisms and potentially identifying lineage-specific vulnerabilities that could be exploited for antifungal development .

How can structural biology approaches advance our understanding of ERG25 catalytic mechanism?

Structural biology techniques can provide critical insights into ERG25 function:

• Structural Determination Strategies:

  • Cryo-EM:

    • Single-particle analysis of purified ERG25

    • Visualization of potential multi-enzyme complexes

    • Conformational states during catalytic cycle

  • X-ray Crystallography:

    • Lipidic cubic phase crystallization for membrane proteins

    • Co-crystallization with substrates or inhibitors

    • Structure determination of soluble domains

  • NMR Spectroscopy:

    • Solution NMR of isolated domains

    • Solid-state NMR to study membrane-embedded regions

    • Dynamics analysis of catalytically important regions

• Computational Approaches:

  • Homology modeling based on related monooxygenases

  • Molecular dynamics simulations of membrane integration

  • Docking studies with substrates and potential inhibitors

• Functional Validation:

  • Structure-guided mutagenesis of catalytic residues

  • Chimeric enzyme construction to test domain functions

  • Correlation of structural features with kinetic parameters

• Mechanistic Questions to Address:

  • How do the histidine-rich clusters coordinate metal ions?

  • What is the structural basis for sequential oxidation of the C-4 methyl group?

  • How does the enzyme interact with membrane-embedded sterol substrates?

  • What structural changes occur during the catalytic cycle?

Structural insights into ERG25 would significantly advance our understanding of sterol metabolism and potentially guide the development of selective inhibitors with applications in antifungal therapy .